Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Haematologica|March 24, 2022
Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL studyAlejandro Martín García-Sancho, Monica Bellei, Miriam López-Parra, et al.
Human Vaccines & Immunotherapeutics|August 18, 2021
Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practiceEdward A Stadtmauer, Keith M Sullivan, Mohamed El Idrissi, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 10, 2022
Prognostic Value of Serum Paraprotein Response Kinetics in Patients With Newly Diagnosed Multiple MyelomaLuis-Esteban Tamariz-Amador, Paula Rodríguez-Otero, Ana Jiménez-Ubieto, et al.
Haematologica|November 30, 2023
Recovery of uninvolved heavy/light chain pair immunoparesis in newly diagnosed transplant-eligible myeloma patients complements the prognostic value of minimal residual disease detectionSunil Lakhwani, Laura Rosiñol, Noemí Puig, et al.
Blood|August 24, 2012
Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopeniaTadeusz Robak, Jerzy Windyga, Jacek Trelinski, et al.
Haematologica|March 21, 2019
High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by three years of rituximab maintenanceJosé A García-Marco, Javier López Jiménez, Valle Recasens, et al.
Journal of Clinical Medicine|October 28, 2023
Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI)María Eva Mingot-Castellano, Mariana Canaro Hirnyk, Blanca Sánchez-González, et al.
Annals of Hematology|October 22, 2024
Immunoparesis recovery in newly diagnosed transplant ineligible multiple myeloma patients, an independent prognostic factor that complements minimal residual diseaseSunil Lakhwani, María Victoria Mateos, Joaquín Martínez-López, et al.
American Journal of Hematology|October 12, 2024
Avatrombopag in immune thrombocytopenia: A real-world study of the Spanish ITP Group (GEPTI)Cristina Pascual-Izquierdo, Blanca Sánchez-González, Mariana-Isabel Canaro-Hirnyk, et al.
Blood Cancer Journal|April 20, 2022
A simple score to predict early severe infections in patients with newly diagnosed multiple myelomaCristina Encinas, José-Ángel Hernandez-Rivas, Albert Oriol, et al.
Pageof 12